当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析 - 现金流量表

易瑞生物

(300942)

  

流通市值:22.52亿  总市值:22.52亿
流通股本:4.05亿   总股本:4.05亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金249,537,366.19165,248,017.2278,030,546.98288,107,810.78
  收到的税费返还---14,381.9
  收到其他与经营活动有关的现金10,877,547.548,057,914.633,169,030.1655,930,576.01
  经营活动现金流入小计260,414,913.73173,305,931.8581,199,577.14344,052,768.69
  购买商品、接受劳务支付的现金130,080,567.9879,796,442.0145,638,455.27126,468,276.36
  支付给职工以及为职工支付的现金86,332,671.5758,394,395.1730,760,409.6793,427,919.88
  支付的各项税费6,043,285.885,451,883.31,385,421.916,364,879.76
  支付其他与经营活动有关的现金57,776,687.8635,534,958.915,942,736.950,919,878.85
  经营活动现金流出小计280,233,213.29179,177,679.3893,727,023.75277,180,954.85
  经营活动产生的现金流量净额-19,818,299.56-5,871,747.53-12,527,446.6166,871,813.84
二、投资活动产生的现金流量:
  收回投资收到的现金12,590,898.3812,590,898.3812,590,898.3820,598,934.48
  取得投资收益收到的现金4,429,088.831,847,307.621,231,761.635,175,260.22
  处置固定资产、无形资产和其他长期资产收回的现金净额534,500494,30070,00029,177,317.56
  处置子公司及其他营业单位收到的现金净额---359,143.42
  收到的其他与投资活动有关的现金488,586,342.44377,162,374.1696,740,505.48810,694,720.8
  投资活动现金流入小计506,140,829.65392,094,880.16110,633,165.49866,005,376.48
  购建固定资产、无形资产和其他长期资产支付的现金40,623,073.8835,701,536.5133,927,808.3645,899,685.49
  投资支付的现金--017,000,000
  支付其他与投资活动有关的现金376,656,900.52318,459,279.8648,386,590.73764,596,157.31
  投资活动现金流出小计417,279,974.4354,160,816.3782,314,399.09827,495,842.8
  投资活动产生的现金流量净额88,860,855.2537,934,063.7928,318,766.438,509,533.68
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,095,0003,095,0003,005,000640,000
  其中:子公司吸收少数股东投资收到的现金3,095,0003,095,0003,005,000640,000
  取得借款收到的现金21,765,781.2821,765,781.2821,765,781.2826,688,827.62
  收到其他与筹资活动有关的现金---0
  筹资活动现金流入小计24,860,781.2824,860,781.2824,770,781.2827,328,827.62
  偿还债务支付的现金30,651,820.1716,434,546.7813,217,227.0940,988,926.84
  分配股利、利润或偿付利息支付的现金16,270,573.1513,228,792.441,904,705.3913,857,304.2
  其中:子公司支付给少数股东的股利、利润578,704.58578,704.58--
  支付其他与筹资活动有关的现金---0
  筹资活动现金流出小计46,922,393.3229,663,339.2215,121,932.4854,846,231.04
  筹资活动产生的现金流量净额-22,061,612.04-4,802,557.949,648,848.8-27,517,403.42
四、汇率变动对现金及现金等价物的影响-15,034,787.22-11,223,441.47-6,680,492.72986,297.22
五、现金及现金等价物净增加额31,946,156.4316,036,316.8518,759,675.8778,850,241.32
  加:期初现金及现金等价物余额335,982,200.74335,982,200.74335,982,200.74257,131,959.42
  期末现金及现金等价物余额367,928,357.17352,018,517.59354,741,876.61335,982,200.74
补充资料:
  净利润--19,396,770.83-15,466,356.76
  资产减值准备-2,697,222.96-10,343,338.84
  固定资产和投资性房地产折旧-16,999,448.48-27,937,033.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-16,999,448.48-27,937,033.57
  无形资产摊销-973,065.78-1,941,548.19
  长期待摊费用摊销-383,186.1-705,773.71
  处置固定资产、无形资产和其他长期资产的损失-119,593.88--12,214,552.49
  固定资产报废损失-932,765.31--117,992.17
  公允价值变动损失--3,132,844.98--2,949,322.7
  财务费用-27,550,198.48-26,492,015.63
  投资损失-1,494,351-8,145,643.14
  递延所得税--4,808,005.68--6,967,616.7
  其中:递延所得税资产减少--4,808,005.68--6,967,616.7
    递延所得税负债增加-0--
  存货的减少--9,986,270.43--16,720,289.81
  经营性应收项目的减少--11,342,922.12--20,548,794.3
  经营性应付项目的增加--3,470,697.51-39,277,628.28
  其他--4,884,067.97--3,918,956.11
  现金的期末余额-352,018,517.59-335,982,200.74
  减:现金的期初余额-335,982,200.74-257,131,959.42
  现金及现金等价物的净增加额-16,036,316.85-78,850,241.32
公告日期2026-10-282026-08-282026-04-272026-04-27
审计意见(境内)标准无保留意见
TOP↑